A meta-analysis of receptor for advanced glycation end products gene: Four well-evaluated polymorphisms with diabetes mellitus

Molecular and Cellular Endocrinology

Volumn 358, Issue 1, 2012, Pages 9-17

  Niu, Wenquan ^a,b   Qi, Yue ^c   Wu, Zhijun ^a   Liu, Yan ^a   Zhu, Dingliang ^a,b   Jin, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Hypertension   (China)

^c BEIJING INSTITUTE OF HEART   (China)

Author keywords

Association; Diabetes mellitus; Meta analysis; Polymorphism; RAGE

Indexed keywords

HEMOGLOBIN A1C;

AGE; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; ETHNICITY; GENDER; GENE; GENE FREQUENCY; GENE MAPPING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HEMOGLOBIN BLOOD LEVEL; HOMOZYGOSITY; HUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RAGE GENE; SEX DIFFERENCE; SKIN DISEASE; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

EID: 84862823013     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.02.010     Document Type: Article

References (44)

1. Balasubbu S., Sundaresan P., Rajendran A., Ramasamy K., Govindarajan G., Perumalsamy N., Hejtmancik J.F. Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med. Genet. 2010, 11:158.
2. Blech I., Katzenellenbogen M., Katzenellenbogen A., Wainstein J., Rubinstein A., Harman-Boehm I., Cohen J., Pollin T.I., Glaser B. Predicting diabetic nephropathy using a multifactorial genetic model. PLoS ONE 2011, 6:e18743.
3. Bucciarelli L.G., Wendt T., Qu W., Lu Y., Lalla E., Rong L.L., Goova M.T., Moser B., Kislinger T., Lee D.C., Kashyap Y., Stern D.M., Schmidt A.M. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 2002, 106:2827-2835.
4. Cohn L.D., Becker B.J. How meta-analysis increases statistical power. Psychol. Methods 2003, 8:243-253.
5. Forbes J.M., Soderlund J., Yap F.Y., Knip M., Andrikopoulos S., Ilonen J., Simell O., Veijola R., Sourris K.C., Coughlan M.T., Forsblom C., Slattery R., Grey S.T., Wessman M., Yamamoto H., Bierhaus A., Cooper M.E., Groop P.H. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia 2011, 54:1032-1042.
6. Gao J.X., Xu D.L., Shao Y.H., Lao W.Y., Lin S., Zhang B. Association of Gly82Ser polymorphism of receptor for advanced glycation end products gene in a type 2 diabetic Chinese population. Nan Fang Yi Ke Da Xue Xue Bao 2007, 27:219-222.
7. Globocnik Petrovic M., Steblovnik K., Peterlin B., Petrovic D. The - 429 T/C and - 374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin Monbl Augenheilkd 2003, 220:873-876.
8. Goldin A., Beckman J.A., Schmidt A.M., Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006, 114:597-605.
9. Goulart A.C., Germer S., Rexrode K.M., Martin M., Zee R.Y. Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 diabetes mellitus. Clin. Chim. Acta. 2008, 398:95-98.
10. Hemminki K., Lorenzo Bermejo J., Forsti A. The balance between heritable and environmental aetiology of human disease. Nat. Rev. Genet. 2006, 7:958-965.
11. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
12. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
13. Hudson B.I., Schmidt A.M. RAGE: a novel target for drug intervention in diabetic vascular disease. Pharm. Res. 2004, 21:1079-1086.
14. Hudson B.I., Stickland M.H., Futers T.S., Grant P.J. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001, 50:1505-1511.
15. Kankova K., Beranek M., Hajek D., Vlkova E. Polymorphisms 1704G/T, 2184A/G, and 2245G/A in the rage gene are not associated with diabetic retinopathy in NIDDM: pilot study. Retina 2002, 22:119-121.
16. Kankova K., Marova I., Zahejsky J., Muzik J., Stejskalova A., Znojil V., Vacha J. Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status. Metabolism 2001, 50:1152-1160.
17. Kankova K., Stejskalova A., Hertlova M., Znojil V. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol. Dial. Transplant. 2005, 20:1093-1102.
18. Kankova K., Zahejsky J., Marova I., Muzik J., Kuhrova V., Blazkova M., Znojil V., Beranek M., Vacha J. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J. Diabetes Complications 2001, 15:185-192.
19. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., Schouten E.G. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002, 288:2023-2031.
20. Kucukhuseyin O., Aydogan H.Y., Isbir C.S., Isbir T. Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease. In Vivo 2009, 23:949-954.
21. Kucukhuseyin O., Yilmaz-Aydogan H., Isbir C.S., Isbir T. Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?. Mol. Biol. Rep. 2011.
22. Kumaramanickavel G., Ramprasad V.L., Sripriya S., Upadyay N.K., Paul P.G., Sharma T. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J. Diabetes Complications 2002, 16:391-394.
23. Lindholm E., Bakhtadze E., Sjogren M., Cilio C.M., Agardh E., Groop L., Agardh C.D. The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 2006, 49:2745-2755.
24. Matsunaga-Irie S., Maruyama T., Yamamoto Y., Motohashi Y., Hirose H., Shimada A., Murata M., Saruta T. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 2004, 27:303-307.
25. Naka C.L., Picheth G., Alcantera V.M., Rea R.R., Chautard-Freire-Maia E.A., Pedrosa Fde O., Martinez T.L., Souza E.M. The Gly82Ser polymorphism of the receptor of advanced glycation end product (RAGE) gene is not associated with type 1 or type 2 diabetes in a Brazilian population. Diabetes Care 2006, 29:712-713.
26. Poirier O., Nicaud V., Vionnet N., Raoux S., Tarnow L., Vlassara H., Parving H.H., Cambien F. Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patients. Diabetes 2001, 50:1214-1218.
27. Prasad P., Tiwari A.K., Kumar K.M., Ammini A.C., Gupta A., Gupta R., Thelma B.K. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Med. Genet. 2010, 11:52.
28. Prevost G., Fajardy I., Besmond C., Balkau B., Tichet J., Fontaine P., Danze P.M., Marre M. Polymorphisms of the receptor of advanced glycation end products (RAGE) and the development of nephropathy in type 1 diabetic patients. Diabetes Metab. 2005, 31:35-39.
29. Ramprasad S., Radha V., Mathias R.A., Majumder P.P., Rao M.R., Rema M. Rage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India. Eye (Lond) 2007, 21:395-401.
30. Santos I.C., Daga D.R., Frigeri H.R., Rea R.R., Almeida A.C., Souza E.M., Pedrosa F.O., Fadel-Picheth C.M., Picheth G. The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians. Genet. Mol. Res. 2010, 9:1130-1135.
31. Schmidt A.M., Stern D.M. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol. Metab. 2000, 11:368-375.
32. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001, 108:949-955.
33. Smith G.D., Harbord R., Milton J., Ebrahim S., Sterne J.A. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies. Arterioscler Thromb. Vasc. Biol. 2005, 25:2228-2233.
34. Soro-Paavonen A., Watson A.M., Li J., Paavonen K., Koitka A., Calkin A.C., Barit D., Coughlan M.T., Drew B.G., Lancaster G.I., Thomas M., Forbes J.M., Nawroth P.P., Bierhaus A., Cooper M.E., Jandeleit-Dahm K.A. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008, 57:2461-2469.
35. Sugaya K., Fukagawa T., Matsumoto K., Mita K., Takahashi E., Ando A., Inoko H., Ikemura T. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 1994, 23:408-419.
36. Thomas M.C., Soderlund J., Lehto M., Makinen V.P., Moran J.L., Cooper M.E., Forsblom C., Groop P.H. Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia 2011, 54:2669-2677.
37. Uthra S., Raman R., Mukesh B.N., Rajkumar S.A., Kumari P., Lakshmipathy P., Gnanamoorthy P., Sharma T., McCarty C.A., Kumaramanickavel G. Diabetic retinopathy: Validation study of ALR2, RAGE, iNOS and TNFB gene variants in a south Indian cohort. Ophthalmic Genet. 2010, 31:244-251.
38. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E685-694.
39. Xu J., Xu B., Yang M., Liu S., Wang C., Sun H., Liu J., Wu D., Xu X. - 429T/C polymorphism of RAGE gene promoter is associated with type 2 diabetic nephropathy. Chin. J. Endocrinol. Metab. 2004, 20:534-535.
40. Xu J., Yang M., Liu J., Chang Y., Zhang P., Chen H. Association between RAGE gene promoter - 374T/A polymorphism and type II diabetes and nephropathy. Chin. J. Prev. Contr. Chron. Dis. 2005, 13:39-40.
41. Yamagishi S., Matsui T., Nakamura K. Blockade of the advanced glycation end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial intervention on mortality in type 2 diabetes. Med. Hypotheses 2008, 71:749-751.
42. Yoshioka K., Yoshida T., Takakura Y., Umekawa T., Kogure A., Toda H., Yoshikawa T. Association study of G1704T and G82S polymorphisms of RAGE gene for microalbuminuria in Japanese type 2 diabetic patients. Metabolism 2005, 54:488-491.
43. Yu K., Zhang J., Dou C., Gu S., Xie Y., Mao Y., Ji C. Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur. J. Hum. Genet. 2010, 18:370-378.
44. Zhang H.M., Chen L.L., Wang L., Liao Y.F., Wu Z.H., Ye F., Xu S., Yi L.L. Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. J. Endocrinol. Invest. 2009, 32:258-262.